Skip to main content
Skip to footer

Evelo

Immune Mechanisms of the Systemic Effects of EDP1815: An Orally Delivered, Gut-Restricted Microbial Drug Candidate for the Treatment of Inflammatory Diseases

Home/Posters/Immune Mechanisms of the Systemic Effects of EDP1815: An Orally Delivered, Gut-Restricted Microbial Drug Candidate for the Treatment of Inflammatory Diseases

January 12, 2021 by

Footer

© Evelo Biosciences, Inc.